BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19691535)

  • 41. Three novel mutations in the gap junction beta 1 (GJB1) gene coding region identified in Charcot-Marie-Tooth patients of Greek origin: T55I, R164Q, V120E. Mutation in brief no 236. Online.
    Karadimas C; Panas M; Chronopoulou P; Avramopoulos D; Vassilopoulos D
    Hum Mutat; 1999; 13(4):339. PubMed ID: 10220155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Charcot-Marie-Tooth type X: A novel mutation in the Cx32 gene with central conduction slowing.
    Seeman P; Mazanec R; Ctvrtecková M; Smilková D
    Int J Mol Med; 2001 Oct; 8(4):461-8. PubMed ID: 11562788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical characterization and genetic analysis of a possible novel type of dominant Charcot-Marie-Tooth disease.
    Lee YC; Lee TC; Lin KP; Lin MW; Chang MH; Soong BW
    Neuromuscul Disord; 2010 Aug; 20(8):534-9. PubMed ID: 20627571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic yield of targeted sequential and massive panel approaches for inherited neuropathies.
    Padilha JPD; Brasil CS; Hoefel AML; Winckler PB; Donis KC; Brusius-Facchin AC; Saute JAM
    Clin Genet; 2020 Aug; 98(2):185-190. PubMed ID: 32506583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two missense mutations of EGR2 R359W and GJB1 V136A in a Charcot-Marie-Tooth disease family.
    Chung KW; Sunwoo IN; Kim SM; Park KD; Kim WK; Kim TS; Koo H; Cho M; Lee J; Choi BO
    Neurogenetics; 2005 Sep; 6(3):159-63. PubMed ID: 15947997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
    Niemann A; Berger P; Suter U
    Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
    Sereda MW; Meyer zu Hörste G; Suter U; Uzma N; Nave KA
    Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Charcot-Marie-Tooth disease: genetic subtypes in the Sardinian population.
    Lorefice L; Murru MR; Coghe G; Fenu G; Corongiu D; Frau J; Tranquilli S; Tacconi P; Vannelli A; Marrosu G; Mamusa E; Cocco E; Marrosu MG
    Neurol Sci; 2017 Jun; 38(6):1019-1025. PubMed ID: 28286897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Charcot-Marie-Tooth 1B caused by expansion of a familial myelin protein zero (MPZ) gene duplication.
    Speevak MD; Farrell SA
    Eur J Med Genet; 2013 Oct; 56(10):566-9. PubMed ID: 23811036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. X-linked Charcot-Marie-Tooth disease predominates in a cohort of multiethnic Malaysian patients.
    Shahrizaila N; Samulong S; Tey S; Suan LC; Meng LK; Goh KJ; Ahmad-Annuar A
    Muscle Nerve; 2014 Feb; 49(2):198-201. PubMed ID: 23649551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients.
    Rudnik-Schöneborn S; Tölle D; Senderek J; Eggermann K; Elbracht M; Kornak U; von der Hagen M; Kirschner J; Leube B; Müller-Felber W; Schara U; von Au K; Wieczorek D; Bußmann C; Zerres K
    Clin Genet; 2016 Jan; 89(1):34-43. PubMed ID: 25850958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
    Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
    Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Charcot-Marie-Tooth disease and related peripheral neuropathies: novel mutations in the peripheral myelin genes connexin 32 (Cx32), peripheral myelin protein 22 (PMP22), and peripheral myelin protein zero (MPZ).
    Ekici AB; Schweitzer D; Park O; Lorek D; Rautenstrauss B; Krüger G; Friedl W; Uhlhaas S; Bathke K; Heuss D; Kayser C; Grehl H
    Neurogenetics; 2000 Sep; 3(1):49-50. PubMed ID: 11085599
    [No Abstract]   [Full Text] [Related]  

  • 55. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
    Berger P; Niemann A; Suter U
    Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B.
    Matsuyama W; Nakagawa M; Takashima H; Osame M
    Acta Neuropathol; 2002 May; 103(5):501-8. PubMed ID: 11935267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and in silico evidence for and against pathogenicity of 11 new mutations in the MPZ gene.
    Brozková D; Mazanec R; Haberlová J; Sakmaryová I; Seeman P
    Clin Genet; 2010 Jul; 78(1):81-7. PubMed ID: 20456450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Genetic diagnosis and molecular pathology of inherited neuropathy].
    Takashima H
    Rinsho Shinkeigaku; 2012; 52(6):399-404. PubMed ID: 22790800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and genetic spectra of Charcot-Marie-Tooth disease in Chinese Han patients.
    Sun B; Chen Z; Ling L; Yang F; Huang X
    J Peripher Nerv Syst; 2017 Mar; 22(1):13-18. PubMed ID: 27862672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Detection of duplications or deletions of the PMP22 gene using real-time quantitative PCR].
    Zhang FF; Tang BS; Shen Y; Zhao GH; Xia K; Zhao YQ; Chen B; Zhang C; Pan Q; Cai F; Liu XM; Luo W; Zhang RX; Guo P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):537-40. PubMed ID: 16215943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.